Related Experiment Videos
The prophylaxis of bacterial infections in neutropenic patients
1Department of Microbiology, University of Leeds, Leeds LS2 9JT, UK.
The Journal of Antimicrobial Chemotherapy
|December 20, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prevalence of Listeria spp. on the Hands of Food Workers.
Journal of food protection·2019
Spectrum of enteropathogens detected by the FilmArray GI Panel in a multicentre study of community-acquired gastroenteritis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Pseudomonas aeruginosa: a formidable and ever-present adversary.
The Journal of hospital infection·2009
Case report: Rhodococcus erythropolis osteomyelitis in the toe.
Clinical orthopaedics and related research·2009
A new tool for the management of infection in patients with febrile neutropenia.
Journal of medical engineering & technology·2009
Best practice in primary care pathology: review 7.
Journal of clinical pathology·2006
Weight-based polymyxin B dosing for mortality and nephrotoxicity: an exploratory dose-response study.
The Journal of antimicrobial chemotherapy·2026
A multinational genomic framework for predicting β-lactam resistance in Haemophilus influenzae.
The Journal of antimicrobial chemotherapy·2026
In silico resistance prediction of oral streptococci to recommended prophylactic antibiotics to prevent infective endocarditis upon dental procedures.
The Journal of antimicrobial chemotherapy·2026
Cefoxitin versus cefotaxime as empirical treatment of spontaneous bacterial peritonitis in liver cirrhotic patients: randomized controlled clinical trial.
The Journal of antimicrobial chemotherapy·2026
BV100 (rifabutin IV) drug interaction studies in healthy subjects with index CYP450 3A probes midazolam and itraconazole.
The Journal of antimicrobial chemotherapy·2026
Systematic screening identified broad-spectrum inhibitors of human-pathogenic Encephalitozoon species and revealed no in vitro activity of nitazoxanide.
The Journal of antimicrobial chemotherapy·2026